Doxorubicin Hydrochloride Powder for Injection

Pfizer Inc

Revision date : 2011-03-16

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating 5
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

202-785-7/99-76-3

Name of the chemical

4-hydroxybenzoic acid, methyl ester

Concentration

*

EC/CAS

200-559-2/63-42-3

Name of the chemical

Lactose C12H22O11

Concentration

*

General Information

Version

3.0

Revision date

2011-03-16

Product name

Doxorubicin Hydrochloride Powder for Injection

Product name

Doxorubicin Hydrochloride Powder for Injection

Identification on the label/Trade name

Adriamycin, Adriblastina

Product Synonyms

Doxorubicin RDF Injection

Chemical name

Mixture

1.2.1 Relevant identified uses

Pharmaceutical product used as Antineoplastic

Emergency telephone

1-800-424-9300, +44 (0)208 76...

Icons in SDS

M004 M009 M010 M011 M017

Company Information

company name

Pfizer Inc

e-mail address of the competent person responsible for the Safety Data Sheet

pfizer-MSDS@pfizer.com

GHS Information

Signal word

DANGER

Hazard Codes

Hazard statements (CLP)

H340, H350, H360

Hazard statements

Code

Statements

H340

May cause genetic defects

Section 2

SECTION 2: Hazards identification

Appearance Red-orange powder

Signal word

DANGER

Hazard statements

May damage fertility or the unborn child. May cause cancer. May cause genetic defects.

Additional information

Short Term Effects of ingestion are not known. Avoid swallowing this material. Drugs of this class have been associated with rare, but potentially serious cardiac events. These events have not been observed from occupational exposures, however, those with preexisting cardiovascular illnesses may be at increased risk from exposure. Long Term Repeat-dose studies in animals have shown a potential to cause adverse effects on testes, the developing fetus. Known Clinical Effects Bone marrow suppression is the most serious adverse effect seen during clinical use. EU Indication of danger Toxic to reproduction, Category 2 Carcinogenic: Category 2 Mutagenic: Category 2 EU Hazard Symbols EU Risk Phrases R45 - May cause cancer. R46 - May cause heritable genetic damage. R60 - May impair fertility. R61 - May cause harm to the unborn child. Australian Hazard Classification (NOHSC)

Hazardous Ingredients

Non-Dangerous Goods Note This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.